pd 98059 has been researched along with Proliferative Vitreoretinopathy in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weng, CY | 1 |
Kothary, PC | 1 |
Verkade, AJ | 1 |
Reed, DM | 1 |
Del Monte, MA | 1 |
Bando, H | 1 |
Ikuno, Y | 1 |
Hori, Y | 1 |
Sayanagi, K | 1 |
Tano, Y | 1 |
2 other studies available for pd 98059 and Proliferative Vitreoretinopathy
Article | Year |
---|---|
MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE).
Topics: Cell Culture Techniques; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Extrac | 2009 |
Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction.
Topics: Androstadienes; Cell Line; Collagen; Enzyme Inhibitors; Extracellular Matrix; Flavonoids; Flow Cytom | 2006 |